26.05.2023 MEDIQON Group AG  DE0006618309

EQS-News: MEDIQON Group AG: Expansion of Capital Base to Accelerate Growth


 

EQS-News: MEDIQON Group AG / Key word(s): Corporate Action
MEDIQON Group AG: Expansion of Capital Base to Accelerate Growth

26.05.2023 / 08:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


As announced in the ad-hoc release of May 26, 2023, MEDIQON Group AG has successfully completed a share capital increase and a bond placing of the 2020 perpetual bond.

Both transactions will raise circa EUR 16 million in additional funds for the Group. These proceeds will be invested to further accelerate the Group’s growth. Furthermore, the company intents to make repurchase offers for the entire outstanding amounts of the 2020 perpetual bond within two years financed from existing cash or, alternatively, by issuing shares at a price of at least EUR 18.00 per share.

Jan-Hendrik Mohr, CEO of MEDIQON Group AG commented:

"The platform companies of MEDIQON Group AG are growing in 2023 as well. Today, we are happy to announce the raising of additional funds to put our growth on a solid footing. We would like to thank our teams for the excellent and our shareholders and bondholders for the great trust in our work.“



26.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MEDIQON Group AG
Herzog-Adolph-Strasse 2
61462 Königstein im Taunus
Germany
Phone: +49 (0) 6174-9687040
Fax: +49 (0) 6174-9687043
E-mail: [email protected]
Internet: www.mediqon-group.de
ISIN: DE0006618309, DE000A254TL0
WKN: 661830, A254TL
Listed: Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1642503

 
End of News EQS News Service

1642503  26.05.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1642503&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 3,21 2,64 0,10 1,08 28,66 42,07 0,00
EBITDA1,2 0,72 8,99 -0,44 -0,61 6,21 10,50 0,00
EBITDA-Marge3 22,43 340,53 -440,00 -56,48 21,67 24,96
EBIT1,4 0,51 8,65 -5,51 -2,56 0,94 2,51 0,00
EBIT-Marge5 15,89 327,65 -5.510,00 -237,04 3,28 5,97 0,00
Jahresüberschuss1 0,54 7,51 -5,01 -2,27 -2,27 -6,60 0,00
Netto-Marge6 16,82 284,47 -5.010,00 -210,19 -7,92 -15,69 0,00
Cashflow1,7 0,75 7,85 -5,00 -1,13 2,87 5,69 0,00
Ergebnis je Aktie8 0,24 3,04 -1,50 -0,18 0,38 0,05 0,23
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Chapters Group
WKN Kurs in € Einschätzung Börsenwert in Mio. €
661830 23,000 Kaufen 379,48
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
46,00 17,40 2,64 73,02
KBV KCV KUV EV/EBITDA
3,89 66,66 9,02 39,56
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 09.07.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
29.09.2023 24.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
15,40% 40,12% 25,68% 61,97%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MEDIQON Group AG  ISIN: DE0006618309 können Sie bei EQS abrufen


Beteiligungen , 661830 , CHG , XETR:CHG